TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Fujirebio Diagnostics AB
Closing information (x1000 NOK)
| Closing information | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Turnover |
329,507
|
326,030
|
312,309 |
| Financial expenses |
16,021
|
4,400
|
84 |
| Earnings before taxes |
145,207
|
170,299
|
178,235 |
| EBITDA |
167,427
|
175,900
|
184,725 |
| Total assets |
759,329
|
786,373
|
647,555 |
| Current assets |
452,907
|
483,409
|
337,045 |
| Current liabilities |
114,427
|
123,292
|
50,028 |
| Equity capital |
635,703
|
654,748
|
589,839 |
| - share capital |
674
|
651
|
644 |
| Employees (average) |
93
|
89
|
86 |
Financial ratios
| Fiscal year | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Solvency |
83.7%
|
83.3%
|
91.1% |
| Turnover per employee |
3,543
|
3,663
|
3,632 |
| Profit as a percentage of turnover |
44.1%
|
52.2%
|
57.1% |
| Return on assets (ROA) |
21.2%
|
22.2%
|
27.5% |
| Current ratio |
395.8%
|
392.1%
|
673.7% |
| Return on equity (ROE) |
22.8%
|
26.0%
|
30.2% |
| Change turnover |
-8,371
|
10,456
|
45,959 |
| Change turnover % |
-2%
|
3%
|
17% |
| Chg. No. of employees |
4
|
3
|
11 |
| Chg. No. of employees % |
4%
|
3%
|
15% |
Total value of public sale
| Fiscal year | 2025/03 (consolidated) | 2024/03 (consolidated) | 2023/03 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.